Quest Laboratories Ltd
Company Profile
Business description
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
Contact
Sector III
Plot No. 45, Pithampur Industrial Area
Opposite Kissan Pipe Unit 4
District Dhar, Pithampur
DharMP454775
INDT: +91 7292292374
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 March 2027
Employees
50
Stocks News & Analysis
stocks
Our top ASX picks in every sector
stocks
Tesla: Shares fall as deliveries come in below consensus
stocks
Will Australia’s dwindling fuel supplies impact this share?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,921.20 | 4.30 | -0.05% |
| CAC 40 | 7,950.33 | 12.06 | -0.15% |
| DAX 40 | 23,032.98 | 135.10 | -0.58% |
| Dow JONES (US) | 46,357.71 | 312.17 | -0.67% |
| FTSE 100 | 10,378.18 | 58.11 | -0.56% |
| HKSE | 25,116.53 | 177.50 | -0.70% |
| NASDAQ | 21,833.04 | 163.30 | -0.74% |
| Nikkei 225 | 53,429.56 | 15.88 | 0.03% |
| NZX 50 Index | 13,069.66 | 167.51 | 1.30% |
| S&P 500 | 6,569.87 | 41.96 | -0.63% |
| S&P/ASX 200 | 8,728.80 | 1.50 | -0.02% |
| SSE Composite Index | 3,919.29 | 29.27 | -0.74% |